Retinoic acid syndrome: a problem of the past? (original) (raw)

References

1. Tallman MS, Andersen JW, Schiffer CA, Appelbaum FR, Feusner JH, Ogden A, Shepherd L, Willman C, Bloomfield CD, Rowe JM, Wiernik PH . All-trans retinoic acid in acute promyelocytic leukemia N Engl J Med 1997 337: 1021–1028
   Article CAS PubMed Google Scholar
2. Fenaux P, Chastang C, Chevret S, Sanz M, Dombret H, Archimbaud E, Fey M, Rayon C, Huguet F, Sotto JJ, Gardin C, Makhoul PC, Travade P, Solary E, Fegueux N, Bordessoule D, Miguel JS, Link H, Desablens B, Stamatoullas A, Deconinck E, Maloisel F, Castaigne S, Preudhomme C, Degos L . A randomized comparison of all-trans retinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group Blood 1999 94: 1192–1200
   CAS PubMed Google Scholar
3. Sanz MA, Lo Coco F, Martin G, Avvisati G, Rayon C, Barbui T, Diaz-Mediavilla J, Fioritoni G, Gonzalez JD, Liso V, Esteve J, Ferrara F, Bolufer P, Bernasconi C, Gonzalez M, Rodeghiero F, Colomer D, Petti MC, Ribera JM, Mandelli F . Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups Blood 2000 96: 1247–1253
   CAS PubMed Google Scholar
4. Lengfelder E, Reichert A, Schoch C, Haase D, Haferlach T, Loffler H, Staib P, Heyll A, Seifarth W, Saussele S, Fonatsch C, Gassmann W, Ludwig WD, Hochhaus A, Beelen D, Aul C, Sauerland MC, Heinecke A, Hehlmann R, Wormann B, Hiddemann W, Buchner T . Double induction strategy including high dose cytarabine in combination with all-trans retinoic acid: effects in patients with newly diagnosed acute promyelocytic leukemia. German AML Cooperative Group Leukemia 2000 14: 1362–1370
   Article CAS PubMed Google Scholar
5. Sanz MA, Martin G, Rayon C, Esteve J, Gonzalez M, Diaz-Mediavilla J, Bolufer P, Barragan E, Terol MJ, Gonzalez JD, Colomer D, Chillon C, Rivas C, Gomez T, Ribera JM, Bornstein R, Roman J, Calasanz MJ, Arias J, Alvarez C, Ramos F, Deben G . A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARalpha-positive acute promyelocytic leukemia. PETHEMA group Blood 1999 94: 3015–3021
   CAS PubMed Google Scholar
6. Tallman MS, Andersen JW, Schiffer CA, Appelbaum FR, Feusner JH, Ogden A, Shepherd L, Rowe JM, Francois C, Larson RS, Wiernik PH . Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome Blood 2000 95: 90–95
   CAS PubMed Google Scholar
7. Seale J, Delva L, Renesto P, Balitrand N, Dombret H, Scrobohaci ML, Degos L, Paul P, Chomienne C . All-trans retinoic acid rapidly decreases cathepsin G synthesis and mRNA expression in acute promyelocytic leukemia Leukemia 1996 10: 95–101
   CAS PubMed Google Scholar
8. Larson RS, Brown DC, Sklar LA . Retinoic acid induces aggregation of the acute promyelocytic leukemia cell line NB-4 by utilization of LFA-1 and ICAM-2 Blood 1997 90: 2747–2756
   CAS PubMed Google Scholar
9. Brown DC, Tsuji H, Larson RS . All-trans retinoic acid regulates adhesion mechanism and transmigration of the acute promyelocytic leukaemia cell line NB-4 under physiologic flow Br J Haematol 1999 107: 86–98
   Article CAS PubMed Google Scholar
10. Dubois C, Schlageter MH, de Gentile A, Guidez F, Balitrand N, Toubert ME, Krawice I, Fenaux P, Castaigne S, Najean Y et al. Hematopoietic growth factor expression and ATRA sensitivity in acute promyelocytic blast cells Blood 1994 83: 3264–3270
    CAS PubMed Google Scholar
11. De Botton S, Dombret H, Sanz M, Miguel JS, Caillot D, Zittoun R, Gardembas M, Stamatoulas A, Conde E, Guerci A, Gardin C, Geiser K, Makhoul DC, Reman O, de la Serna J, Lefrere F, Chomienne C, Chastang C, Degos L, Fenaux P . Incidence, clinical features, and outcome of all-trans retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. TheEuropean APL Group Blood 1998 92: 2712–2718
    CAS PubMed Google Scholar
12. Evans G, Grimwade D, Prentice HG, Simpson N . Central nervous system relapse in acute promyelocytic leukaemia in patients treated with all-trans retinoic acid Br J Haematol 1997 98: 437–439
    Article CAS PubMed Google Scholar
13. Ueda K, Kume A, Furukawa Y, Higashi N . Cutaneous infiltration in acute promyelocytic leukemia J Am Acad Dermatol 1997 36: 104–106
    Article CAS PubMed Google Scholar
14. Ko BS, Tang JL, Chen YC, Yao M, Wang CH, Shen MC, Tien HF . Extramedullary relapse after all-trans retinoic acid treatment in acute promyelocytic leukemia – the occurrence of retinoic acid syndrome is a risk factor Leukemia 1999 13: 1406–1408
    Article CAS PubMed Google Scholar
15. Vahdat L, Maslak P, Miller WH Jr, Eardley A, Heller G, Scheinberg DA, Warrell RP Jr . Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: impact of leukocytosis, low-dose chemotherapy, PMN/RAR-alpha isoform, and CD13 expression in patients treated with all-trans retinoic acid Blood 1994 84: 3843–3849
    CAS PubMed Google Scholar
16. Firkin FC, Matthews JP, Bradstock KF, Wiley JS . A phase II study of all-trans retinoic acid (ATRA) with prednisolone prophylaxis in the treatment of acute promyelocytic leukemia (APL) Blood 1999 94: 228b (Abstr)
    Google Scholar

Download references